APA Alıntı

Kameshima, H., Tsuruma, T., Kutomi, G., Shima, H., Iwayama, Y., Kimura, Y., . . . Hirata, K. (2012). Immunotherapeutic benefit of α‐interferon (IFNα) in survivin2B‐derived peptide vaccination for advanced pancreatic cancer patients. Cancer Sci.

Chicago Stili Alıntı

Kameshima, Hidekazu, et al. "Immunotherapeutic Benefit of α‐interferon (IFNα) in Survivin2B‐derived Peptide Vaccination for Advanced Pancreatic Cancer Patients." Cancer Sci 2012.

MLA Alıntı

Kameshima, Hidekazu, et al. "Immunotherapeutic Benefit of α‐interferon (IFNα) in Survivin2B‐derived Peptide Vaccination for Advanced Pancreatic Cancer Patients." Cancer Sci 2012.